XUND
PrivateLast Round
Early Funding
Mar 5, 2025
Total Funding Raised
$15.35M
Momentum Score
25 /100
Company Overview
XUND is a healthtech company that develops an AI-powered technology designed to digitize the patient journey, guiding patients from prevention to diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Medical AI, Vertical SaaS, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XUND Comps
Public and private peers based on sector, stage, and business model.
XUND Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 5, 2025 | ||||
| Seed | Apr 2, 2024 | ||||
| Seed | Oct 3, 2022 | ||||
| Angel | Mar 10, 2020 |
Key People
Founding team and executive leadership
XUND Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peak Pride | Seed, Angel |
| Lead Ventures | Early Funding |
| RoX Health | Seed |
| MassMutual Ventures | Seed, Early Funding |
| J&T Ventures | Early Funding |
| MMC Ventures | Seed |
| 2m-quadrat AG | Seed |
XUND Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XUND's valuation, stock price, and market status.